Dynavax Technologies Corp (DVAX)
11.30
-0.12
(-1.09%)
USD |
NASDAQ |
Apr 18, 14:37
Dynavax Technologies Cash from Operations (Quarterly): 13.77M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.77M |
| September 30, 2023 | 31.13M |
| June 30, 2023 | 28.05M |
| March 31, 2023 | 27.62M |
| December 31, 2022 | 34.95M |
| September 30, 2022 | 61.56M |
| June 30, 2022 | 16.65M |
| March 31, 2022 | -50.44M |
| December 31, 2021 | 120.50M |
| September 30, 2021 | 66.21M |
| June 30, 2021 | 110.79M |
| March 31, 2021 | 38.03M |
| December 31, 2020 | -15.74M |
| September 30, 2020 | -27.82M |
| June 30, 2020 | -21.82M |
| March 31, 2020 | -26.87M |
| December 31, 2019 | -23.01M |
| September 30, 2019 | -21.98M |
| June 30, 2019 | -36.36M |
| March 31, 2019 | -39.90M |
| December 31, 2018 | -33.63M |
| September 30, 2018 | -33.87M |
| June 30, 2018 | -33.93M |
| March 31, 2018 | -29.87M |
| December 31, 2017 | -17.75M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.13M |
| June 30, 2017 | -17.39M |
| March 31, 2017 | -25.25M |
| December 31, 2016 | -26.28M |
| September 30, 2016 | -28.21M |
| June 30, 2016 | -25.43M |
| March 31, 2016 | -27.13M |
| December 31, 2015 | -21.85M |
| September 30, 2015 | -23.00M |
| June 30, 2015 | -23.57M |
| March 31, 2015 | -24.14M |
| December 31, 2014 | -16.87M |
| September 30, 2014 | -23.09M |
| June 30, 2014 | -22.61M |
| March 31, 2014 | -11.18M |
| December 31, 2013 | -11.84M |
| September 30, 2013 | -12.26M |
| June 30, 2013 | -15.69M |
| March 31, 2013 | -18.89M |
| December 31, 2012 | -7.592M |
| September 30, 2012 | -12.35M |
| June 30, 2012 | -15.69M |
| March 31, 2012 | -8.181M |
| December 31, 2011 | -5.288M |
| September 30, 2011 | -12.70M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-50.44M
Minimum
Mar 2022
120.50M
Maximum
Dec 2021
17.12M
Average
16.65M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Supernus Pharmaceuticals Inc | 44.96M |
| Ligand Pharmaceuticals Inc | 8.065M |
| Pacira BioSciences Inc | 47.58M |
| Esperion Therapeutics Inc | -37.06M |
| PetIQ Inc | -2.842M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -20.24M |
| Cash from Financing (Quarterly) | 1.776M |
| Free Cash Flow | 96.46M |
| Free Cash Flow Per Share (Quarterly) | 0.0931 |
| Free Cash Flow to Equity (Quarterly) | 11.76M |
| Free Cash Flow to Firm (Quarterly) | 12.04M |
| Free Cash Flow Yield | 6.06% |